- cafead   Dec 13, 2023 at 09:32: AM
via Pfizer’s $43 billion acquisition of cancer and antibody-drug conjugate biotech Seagen has received all regulatory approvals and will close on Dec. 14, the biopharma giant announced on Tuesday.
article source
article source